Drug companies to pay $125 million in AWP settlement


Eleven drug companies settled litigation that charged they knowingly inflated average wholesale price for drugs in the Medicare Part B program.

Eleven pharmaceutical companies have agreed to pay $125 million to settle a case in which they allegedly inflated the average wholesale prices (AWP) on certain prescription drugs in the Medicare Part B program. In separate FirstdataBank and McKesson charging inflation of AWP. Any Medicare Part B beneficiary who was charged a copay from 1991 through 2004 may be eligible for reimbursement under the settlement. Abbott, Amgen, Aventis, Baxter, Bayer, Dey, Fujisawa, Pharmacia & Upjohn, Teva, Watson Pharmaceuticals, and ZLB Behring were all parties to the settlement.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.


Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
Dr. Charles Lee
Dr. Charles Lee
Related Content
© 2024 MJH Life Sciences

All rights reserved.